PCA
IRWD icon

Pallas Capital Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Pallas Capital Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$283K Sell
80,567
-7,408
-8% -$30.4K 0.01% 653
2025
Q4 		$296K Buy
87,975
+406
+0.5% +$1.05K 0.01% 679
2025
Q3 		$115K Buy
87,569
+8,057
+10% +$8.34K ﹤0.01% 824
2025
Q2 		$57K Buy
79,512
+65,172
+454% +$51.2K ﹤0.01% 819
2025
Q1 		$21.1K Buy
+14,340
New +$34.2K ﹤0.01% 741

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Pallas Capital Advisors's IRWD Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 8.4% in Q1 2026, selling an estimated $30.4K and leaving 80,567 shares worth $283K. The position accounts for 0.01% of the portfolio, ranked #653.

Pallas Capital Advisors first reported a position in IRWD in Q1 2025 and has held it in 5 quarters since. The position peaked at $296K in Q4 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Pallas Capital Advisors held 80,567 shares of Ironwood Pharmaceuticals worth $283K as of Q1 2026.
  • Pallas Capital Advisors sold 7,408 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $30.4K.
  • Ironwood Pharmaceuticals made up 0.01% of Pallas Capital Advisors's portfolio in Q1 2026, its #653 holding.
  • Pallas Capital Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Pallas Capital Advisors's Ironwood Pharmaceuticals position peaked at $296K in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.